Cancer Immunology Research

Cancer Immunology Research

癌症免疫学研究

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Cancer Immunology Research》是由American Association for Cancer Research Inc.出版社于2013年创办的英文国际期刊(ISSN: 2326-6066,E-ISSN: 2326-6074),该期刊长期致力于免疫学领域的创新研究,主要研究方向为ONCOLOGY-IMMUNOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.0124...%),以发表免疫学领域等方向的原创性研究为核心(研究类文章占比95.61%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在114篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Immunology Research审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约114篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 114 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
1区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
1区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 20 / 181

89.2%

学科:ONCOLOGY SCIE Q1 35 / 322

89.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 15 / 181

91.99%

学科:ONCOLOGY SCIE Q1 32 / 322

90.22%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15.6 SJR:3.781 SNIP:1.323
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q1 24 / 230

89%

大类:Biochemistry, Genetics and Molecular Biology 小类:Immunology Q1 28 / 236

88%

期刊发文

  • HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy

    Author: Xiao, Bo -Lin; Wang, Xiao-Le; Xia, Hou-Fu; Wang, Kui-Ming; Chen, Zhuo-Kun; Zhong, Ya-Hua; Jiang, Huan-Gang; Zhou, Fu-Xiang; Wang, Wei; Chen, Gai-Li; Chen, Gang

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 228-240. DOI: 10.1158/2326-6066.CIR-22-0277

  • Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis

    Author: Wang, Fang; Niu, Yuequn; Chen, Kelie; Yuan, Xiaoyu; Qin, Yuheng; Zheng, Fang; Cui, Zhenyan; Lu, Weiguo; Wu, Yihua; Xia, Dajing

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 199-216. DOI: 10.1158/2326-6066.CIR-22-0410

  • HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells

    Author: Li, Lili; Hao, Shumin; Gao, Meiling; Liu, Junxiao; Xu, Xin; Huang, Jianfei; Cheng, Genhong; Yang, Heng

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 657-673. DOI: 10.1158/2326-6066.CIR-22-0317

  • Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner

    Author: Long, Yiru; Chen, Runqiu; Yu, Xiaolu; Tong, Yongliang; Peng, Xionghua; Li, Fanglin; Hu, Chao; Sun, Jianhua; Gong, Likun

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 241-260. DOI: 10.1158/2326-6066.CIR-22-0439

  • Discovery of Podofilox as a Potent cGAMP-STING Signaling Enhancer with Antitumor Activity

    Author: Han, Jing; Hu, Shuiqing; Hu, Yawei; Xu, Yifang; Hou, Yanfei; Yang, Yinlong; Su, Huili; Zhang, Zhengyin; Liu, Peng; Sun, Xuxu; Zhang, Conggang

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 583-599. DOI: 10.1158/2326-6066.CIR-22-0483

  • CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer

    Author: Wei, Ye; Xu, Tingting; Li, Chong; Zhou, Xin; Qian, Wei; Shen, Chunying; Wang, Qifeng; Xing, Xing; Ou, Xiaomin; He, Xiayun; Yin, Hongmei; Hu, Chaosu; Wang, Yu; Ji, Qinghai; Su, Fengtao; Lu, Xueguan

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 306-319. DOI: 10.1158/2326-6066.CIR-22-0454

  • Cancer Cell Resistance to IFNg Can Occur via Enhanced Double-Strand Break Repair Pathway Activity

    Author: Han, Tong; Wang, Xujun; Shi, Sailing; Zhang, Wubing; Wang, Jue; Wu, Qiu; Li, Ziyi; Fu, Jingxin; Zheng, Rongbin; Zhang, Jiamin; Tang, Qin; Zhang, Peng; Wang, Chenfei

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 381-398. DOI: 10.1158/2326-6066.CIR-22-0056

  • Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade

    Author: Yan, Bo; Hooper, D. Craig; Yuan, Zhiyong; Wang, Changli; Chen, Yulong; Lu, Bo

    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 546-555. DOI: 10.1158/2326-6066.CIR-21-0839